RxDoctor Payments Data

Jeremy Myers, MD

Urology · Salt Lake City, UTNPI 1346396959

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,925 of the $14,596 with a category attached, or 68.0%. Coopersurgical, Inc. accounts for 63.4% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2020 at $9,099 and has fallen 70.7% since, to $2,662 in 2025.

$14,596in general payments, 2019–2025

Across 48 payments — averaging $304.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coopersurgical, Inc.$9K
  • Intuitive Surgical$3K
  • Boston Scientific$2K
  • Laborie Medical Technologies Corp.$675
  • AbbVie$156
  • Medtronic$141
  • plus $106 from 2 others
$47,094in research payments, 2019–2025

Across 42 payments — averaging $1121.28 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$47K

What the payments were for

  • Consulting fees$9,92568%
  • Travel & lodging$1,0297%
  • Food & beverage$2,14315%
  • Education$1,50010%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,596 in reported general payments places this provider in the 80th percentile of 96 urology providers in Utah.

See all urology providers in Utah

Medicare billing

Part B allowed, 2024
$117,662
Medicare patients
165
Services billed
526

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MyrbetriqMirabegron32$17,802
Gentamicin Sulfate36$1,760
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst15$344
Oxybutynin Chloride ErOxybutynin Chloride27$277
Tamsulosin Hcl11$72
Levofloxacin14$35

Paid to pharmacies, not to this prescriber.

Other urology in Salt Lake City

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →